A new multiple sclerosis treatment halted symptom development in 16 of 24 patients in a study in Canada. The treatment used chemotherapy to wipe out the participants’ immune systems, followed by stem cell therapy to rebuild them. The new immune system no longer attacks the patients’ nerve cells, stopping the disability from worsening. While experts are cautious, they anticipate that this treatment will be the new standard of care for patients with MS.

Read more.